RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Prevalence of trachoma in Benishangul Gumuz Region, Ethiopia, after implementation of the SAFE strategy
Results of four population-based surveys
Mengistu, B., Wirtu, F., Alemayehu, A., Alene, S., Asmare, A., Backers, S., Bakhtiari, A., Brady, M., Butcher, R. M. R., Dayessa, M., Frawley, H., Gebru, G., Jimenez, C., Kebede, F., Kejela, A., McPherson, S., Mihret, A., Negussu, N., Ngondi, J. M., ... Harding-Esch, E. M. (2022). Prevalence of trachoma in Benishangul Gumuz Region, Ethiopia, after implementation of the SAFE strategy: Results of four population-based surveys. Ophthalmic Epidemiology, 1-9. Advance online publication. https://doi.org/10.1080/09286586.2022.2140439
PURPOSE: We aimed to estimate the prevalence of trachomatous inflammation-follicular (TF) in 1-9-year-olds and trachomatous trichiasis (TT) unknown to the health system in ≥15-year-olds in Benishangul Gumuz (BGZ) region, Ethiopia. This will help to assess progress towards the elimination of trachoma as a public health problem and determine the need for future interventions against trachoma in the region.
METHODS: Cross-sectional population-based trachoma prevalence surveys were conducted in four evaluation units (EUs) of BGZ using World Health Organization-recommended survey methodologies. Individuals were examined for clinical signs of trachoma. Household access to water, sanitation and hygiene facilities (WaSH) was assessed.
RESULTS: A total of 11,778 people aged ≥1 year were examined. The prevalence of TF in 1-9-year-olds was <5% in three EUs and ≥5% in one EU. The prevalence of TT unknown to the health system in people aged ≥15-years was ≥0.2% in all four EUs. The proportion of households with an improved drinking water source within a 30-minute round-trip ranged from 27-60%. The proportion of households with an improved latrine ranged from <1-6%.
CONCLUSIONS: Surgical interventions for TT are required in all EUs in BGZ. One annual round of mass drug administration (MDA) of azithromycin is required in one EU before resurvey to reassess progress in lowering TF prevalence below the WHO elimination threshold of 5% in 1-9-year-olds. MDA should be stopped in the other three EUs and trachoma surveillance surveys should be conducted at least 24 months after the surveys described here. Ongoing strengthening of WaSH infrastructure may help sustain the low prevalence of trachoma.